{"id":"W4414043887","doi":"10.1016/j.ijgc.2025.102654","title":"A randomized, phase III study of sacituzumab govitecan versus treatment of the physician’s choice in patients with endometrial cancer after platinum-based chemotherapy and immunotherapy: the ASCENT-GYN-01 study (GOG-3104/ENGOT-en26/APGOT-EN2)","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Health Science Centre","funders":"Gilead UK and Ireland Corporate Contributions; Gilead Sciences","keywords":"Endometrial cancer; Chemotherapy; Phases of clinical research; Cancer; MEDLINE","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002495459,0.001873946,0.002756058,0.0003702111,0.0004644317,0.00129982,0.0009732308,0.002243187,0.007337632],"category_scores_gemma":[0.002730264,0.0007228333,0.00185073,0.0004503332,0.00147273,0.001155163,0.0004279324,0.003493815,0.001157062],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001083022,"about_ca_system_score_gemma":0.001795481,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001223805,"about_ca_topic_score_gemma":0.003372347,"domain_scores_codex":[0.9990533,0.0005840252,0.0000331275,0.0001516561,0.00005646179,0.0001214294],"domain_scores_gemma":[0.998284,0.0004950276,0.0004241796,0.0001306022,0.000104773,0.0005614404],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9850906,0.00682986,0.0003998438,0.0002343324,0.0004451566,0.00002843076,0.00003642156,0.0002465893,0.0007843807,0.0000792606,0.0006570665,0.005168127],"study_design_scores_gemma":[0.9494151,0.04865492,0.000743138,0.00001429522,0.0001928431,0.00002092397,0.00001533709,0.0002601195,0.00013042,0.0001102889,0.0004349133,0.000007681088],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.979603,0.003935185,0.0007911038,0.001230446,0.0009942746,0.008366455,0.001742754,0.0001353044,0.003201494],"genre_scores_gemma":[0.9761081,0.002265741,0.001899245,0.002145984,0.0007072393,0.009438409,0.001890455,0.0000312343,0.005513493],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007337632,"threshold_uncertainty_score":0.0245468,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02113383975050328,"score_gpt":0.3474064422235527,"score_spread":0.3262726024730495,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}